Cerevel Therapeutics Holdings, Inc.

NasdaqCM:CERE Stock Report

Market Cap: US$7.6b

Cerevel Therapeutics Holdings Balance Sheet Health

Financial Health criteria checks 5/6

Cerevel Therapeutics Holdings has a total shareholder equity of $673.7M and total debt of $449.6M, which brings its debt-to-equity ratio to 66.7%. Its total assets and total liabilities are $1.2B and $569.6M respectively.

Key information

66.7%

Debt to equity ratio

US$449.59m

Debt

Interest coverage ration/a
CashUS$990.97m
EquityUS$673.75m
Total liabilitiesUS$569.55m
Total assetsUS$1.24b

Recent financial health updates

Recent updates

Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Shares Could Be 23% Above Their Intrinsic Value Estimate

Jan 02
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Shares Could Be 23% Above Their Intrinsic Value Estimate

Cerevel overweight at Wells Fargo due to candidates with blockbuster potential

Sep 26

Cerevel Therapeutics prices $300M in notes offering, $254M in stock offering

Aug 12

Cerevel Therapeutics GAAP EPS of -$0.61 misses by $0.13

Aug 01

Cerevel: The Next Big Thing In CNS Disease? Maybe If The Market Wasn't So Crowded

Jul 08

Cerevel Therapeutics: Pfizer's Neurology Spin-Off

Jul 14

We're Not Very Worried About Cerevel Therapeutics Holdings' (NASDAQ:CERE) Cash Burn Rate

Jun 09
We're Not Very Worried About Cerevel Therapeutics Holdings' (NASDAQ:CERE) Cash Burn Rate

Is Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Popular Amongst Institutions?

Jan 29
Is Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Popular Amongst Institutions?

Cerevel Therapeutics (CERE) Investor Presentation - Slideshow

Nov 18

Cerevel Therapeutics reports Q3 results

Nov 16

Dosing underway in Cerevel Therapeutics' tavapadon trials for Parkinson’s disease

Oct 30

Financial Position Analysis

Short Term Liabilities: CERE's short term assets ($1.0B) exceed its short term liabilities ($92.2M).

Long Term Liabilities: CERE's short term assets ($1.0B) exceed its long term liabilities ($477.4M).


Debt to Equity History and Analysis

Debt Level: CERE has more cash than its total debt.

Reducing Debt: CERE's debt to equity ratio has increased from 0% to 66.7% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CERE has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: CERE has sufficient cash runway for 2.4 years if free cash flow continues to reduce at historical rates of 32.3% each year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.